Patents by Inventor Laura RUTITZKY

Laura RUTITZKY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240052040
    Abstract: Pharmaceutical preparations containing polypeptides having particular sialylation patterns, and methods for the treatment of immune-related thrombocytopenia with such preparations, are described.
    Type: Application
    Filed: April 19, 2023
    Publication date: February 15, 2024
    Inventors: Birgit C. Schultes, Chia Lin Chu, Laura Rutitzky, Lynn Zhang, Leona E. Ling
  • Patent number: 11661456
    Abstract: Pharmaceutical preparations containing polypeptides having particular sialylation patterns, and methods for the treatment of immune-related thrombocytopenia with such preparations, are described.
    Type: Grant
    Filed: May 21, 2018
    Date of Patent: May 30, 2023
    Assignee: Momenta Pharmaceuticals, Inc.
    Inventors: Birgit C. Schultes, Chia Lin Chu, Laura Rutitzky, Lynn Zhang, Leona E. Ling
  • Publication number: 20220153833
    Abstract: The present invention relates to methods of using biologically active Fc domain-containing therapeutic constructs (Fc constructs) to induce immune cell activation of the immune response in a subject, and for example, to treat diseases such as cancers and infections in a subject. Such Fc constructs may include 5 or more Fc domains.
    Type: Application
    Filed: March 2, 2017
    Publication date: May 19, 2022
    Inventors: Carlos J. Bosques, James S. Huston, Jonathan C. Lansing, Leona E. Ling, James Meador, III, Daniel Ortiz, Laura Rutitzky, Birgit C. Schultes
  • Publication number: 20220064298
    Abstract: Fc-antigen binding constructs having a CTLA-4 binding domain and two or more Fc domains are described as are methods for using such constructs. Also described are polypeptides making up such constructs.
    Type: Application
    Filed: July 11, 2019
    Publication date: March 3, 2022
    Inventors: Anthony Manning, Jonathan C. Lansing, Daniel Ortiz, Laura Rutitzky
  • Publication number: 20220049019
    Abstract: The present disclosure relates to engineered IgG Fc constructs and uses thereof.
    Type: Application
    Filed: October 1, 2021
    Publication date: February 17, 2022
    Inventors: Carlos J. Bosques, Jonathan C. Lansing, Daniel Ortiz, Laura Rutitzky, Nathaniel J. Washburn
  • Publication number: 20220033499
    Abstract: The present invention relates to compositions and methods of engineered IgG Fc constructs, wherein said Fc constructs include one or more Fc domains.
    Type: Application
    Filed: August 20, 2021
    Publication date: February 3, 2022
    Inventors: Carlos J. Bosques, James S. Huston, Jonathan C. Lansing, Leona E. Ling, James Meador, III, Daniel Ortiz, Laura Rutitzky
  • Patent number: 11155640
    Abstract: The present invention relates to engineered IgG Fc constructs and uses thereof.
    Type: Grant
    Filed: May 23, 2017
    Date of Patent: October 26, 2021
    Assignee: Janssen Biotech, Inc.
    Inventors: Carlos J. Bosques, Jonathan C. Lansing, Daniel Ortiz, Laura Rutitzky, Nathaniel J. Washburn
  • Patent number: 11124573
    Abstract: The present invention relates to compositions and methods of engineered IgG Fc constructs, wherein said Fc constructs include one or more Fc domains.
    Type: Grant
    Filed: March 25, 2019
    Date of Patent: September 21, 2021
    Assignee: Janssen Biotech, Inc.
    Inventors: Carlos J. Bosques, James S. Huston, Jonathan C. Lansing, Leona E. Ling, James Meador, III, Daniel Ortiz, Laura Rutitzky
  • Publication number: 20210147549
    Abstract: Fc-antigen binding constructs having a PD-L1 binding domain and two or more Fc domains are described as are methods for using such constructs. Also described are polypeptides making up such constructs. Fc domain monomers that are included in the constructs can include amino acid substitutions that promote homodimerization or heterodimerization.
    Type: Application
    Filed: July 11, 2019
    Publication date: May 20, 2021
    Inventors: Jonathan C. Lansing, Daniel Ortiz, Anthony Manning, Laura Rutitzky
  • Publication number: 20200087402
    Abstract: Pharmaceutical preparations containing polypeptides having particular sialylation patterns, and methods for the treatment of immune-related thrombocytopenia with such preparations, are described.
    Type: Application
    Filed: November 19, 2019
    Publication date: March 19, 2020
    Inventors: Birgit C. Schultes, Chia Lin Chu, Laura Rutitzky, Lynn Zhang, Leona E. Ling
  • Publication number: 20190284305
    Abstract: The present invention relates to engineered IgG Fc constructs and uses thereof.
    Type: Application
    Filed: May 23, 2017
    Publication date: September 19, 2019
    Inventors: Carlos J. Bosques, Jonathan C. Lansing, Daniel Ortiz, Laura Rutitzky, Nathaniel J. Washburn
  • Publication number: 20190225688
    Abstract: The present invention relates to compositions and methods of engineered IgG Fc constructs, wherein said Fc constructs include one or more Fc domains.
    Type: Application
    Filed: March 25, 2019
    Publication date: July 25, 2019
    Inventors: Carlos J. Bosques, James S. Huston, Jonathan C. Lansing, Leona E. Ling, James Meador, III, Daniel Ortiz, Laura Rutitzky
  • Patent number: 10239944
    Abstract: The present invention relates to compositions and methods of engineered IgG Fc constructs, wherein said Fc constructs include one or more Fc domains.
    Type: Grant
    Filed: April 28, 2016
    Date of Patent: March 26, 2019
    Assignee: Momenta Pharmaceuticals, Inc.
    Inventors: Carlos J. Bosques, James S. Huston, Jonathan C. Lansing, Leona E. Ling, James Meador, III, Daniel Ortiz, Laura Rutitzky
  • Publication number: 20180327498
    Abstract: Pharmaceutical preparations containing polypeptides having particular sialylation patterns, and methods for the treatment of immune-related thrombocytopenia with such preparations, are described.
    Type: Application
    Filed: May 21, 2018
    Publication date: November 15, 2018
    Inventors: Birgit C. Schultes, Chia Lin Chu, Laura Rutitzky, Lynn Zhang, Leona E. Ling
  • Publication number: 20170066826
    Abstract: The present invention relates to compositions and methods of engineered IgG Fc constructs, wherein said Fc constructs include one or more Fc domains.
    Type: Application
    Filed: April 28, 2016
    Publication date: March 9, 2017
    Applicant: Momenta Pharmaceuticals, Inc.
    Inventors: Carlos J. BOSQUES, James S. HUSTON, Jonathan C. LANSING, Leona E. LING, James MEADOR, III, Daniel ORTIZ, Laura RUTITZKY, Birgit C. SCHULTES
  • Publication number: 20160257754
    Abstract: Pharmaceutical preparations containing polypeptides having particular sialylation patterns, and methods for the treatment of immune-related thrombocytopenia with such preparations, are described.
    Type: Application
    Filed: October 14, 2014
    Publication date: September 8, 2016
    Applicant: Momenta Pharmaceuticals Inc.
    Inventors: Birgit C. SCHULTES, Chia Lin CHU, Laura RUTITZKY, Lynn ZHANG, Leona E. LING
  • Publication number: 20160229913
    Abstract: The present invention relates to compositions and methods of engineered IgG Fc constructs, wherein said Fc constructs include one or more Fc domains.
    Type: Application
    Filed: April 28, 2016
    Publication date: August 11, 2016
    Inventors: Carlos J. BOSQUES, James S. HUSTON, Jonathan C. LANSING, Leona E. LING, James MEADOR, III, Daniel ORTIZ, Laura RUTITZKY, Birgit C. SCHULTES